Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση του Imatinib Mesylate στη επούλωση των αναστομώσεων παχέος εντέρου: πειραματική μελέτη σε επιμύες

Abstract

dc:description

Large bowel operations often include by an end-to-end anastomosis in order to maintain the continuity of the peptic system. Leakage of colonic anastomosis is a serious postoperative complication that increases morbidity and mortality rates. Several drugs that have been studied were found to have negative impact on the anastomotic integrity. Imatinib mesylate is a new chemotherapeutic agent which is used against chronic myelogenous leukemia and gastrointestinal stromal tumors. Aim of this experimental study was to investigate the possible negative effect of Imatinib mesylate on the colonic anastomosis. Sixty Wistar rats were divided into two groups of thirty animals each group. The study group was given 50 mg/Kg BW/d Imatinib by gavage starting one-week prior the operation and throughout the experiment. Placebo was administered to the control group in equal amounts. Both groups underwent an end-to-end colon anastomosis. They were further subdivided into subgroups of ten animals each and were sacrificed on the 3d, 7th and 14th postoperative day. The mechanical strength of the anastomosis was assessed by measuring the bursting pressure. The anastomoses were also examined macroscopically and microscopically by the electronic microscope. The serum levels of IL-2, IL-6 and TNF-a were measured in all animals. The findings of the two groups were compared by using Mann-Whitney test. Our results indicate that Imatinib mesylate impairs the integrity of colon anastomosis especially during the inflammatory phase. The negative effects of the drug were minimal of the subgroup that was sacrificed on the 7th p.o day and no differences were found between study and control groups of the 14th p.o. day. We believe that these results could to be the outcome of tPDGFR inhibition by Imatinib mesylate. PDGF is known to be an activator of cells that play an important role in the early phases of wound healing. It is responsible for the recruitment, proliferation and gene expression in macrophages, lymphocells and fibroblasts. Based on results of this experimental study, we could claim that Imatinib mesylate has a negative effect on large bowel anastomosis.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Aimoniotou-Georgiou, Eleni
  • Αιμονιώτου-Γεωργίου, Ελένη

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19505

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Aimoniotou-Georgiou, Eleni; Αιμονιώτου-Γεωργίου, Ελένη. Η επίδραση του Imatinib Mesylate στη επούλωση των αναστομώσεων παχέος εντέρου: πειραματική μελέτη σε επιμύες. Aristotle University Of Thessaloniki (AUTH), 2009. http://hdl.handle.net/10442/hedi/19505